Stock Price Target VXRT
| High | $ 18.00 |
|---|---|
| Median | $ 11.50 |
| Low | $ 7.00 |
| Average | $ 12.00 |
| Current Price | $ 5.08 |
Similarly, Is VXRT a buy or sell?
Out of 4 analysts, 3 (75%) are recommending VXRT as a Strong Buy, 0 (0%) are recommending VXRT as a Buy, 1 (25%) are recommending VXRT as a Hold, 0 (0%) are recommending VXRT as a Sell, and 0 (0%) are recommending VXRT as a Strong Sell. What is VXRT’s earnings growth forecast for 2022-2024?
Will VXRT stock go up tomorrow? If this Munafa value is near or nearing 100, then this stock might show an upward movement.
…
Munafa value: 40 as on 08 Fri Apr 2022.
| Downside target | 4.5 |
|---|---|
| Upside target | 4.79 |
| Upside target | 4.87 |
| Upside target | 4.88 |
| Upside target | 5.04 |
Thereof, What is vaxart future?
According to the 4 industry analysts covering Vaxart, the consensus is that breakeven is near. They expect the company to post a final loss in 2022, before turning a profit of US$6.4m in 2023. The company is therefore projected to breakeven around 2 years from today.
How do I buy VXRT stock?
Find the stock by name or ticker symbol – VXRT – and research it before deciding if it’s a good investment for you. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price. Check in on your investment.
Why is VXRT stock dropping?
VXRT Stock Tumbles as Vaxart Struggles to Get in the Game
Johnson & Johnson (NYSE:JNJ) announced Phase 3 trial results of its Covid-19 vaccine in January of this year.
Who is VXRT stock?
(VXRT) Stock Price, News, Quote & History – Yahoo Finance.
…
Performance Outlook.
| Previous Close | 4.8800 |
|---|---|
| Day’s Range | 4.6550 – 4.8700 |
| 52 Week Range | 3.9100 – 11.1100 |
| Volume | 1,515,390 |
| Avg. Volume | 2,417,308 |
Why is VXRT up today?
What happened. Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral coronavirus vaccine. As of 2:20 p.m. EDT, Vaxart’s stock price was up more than 12%.
What happen with VXRT?
(VXRT) Reports Q4 Loss, Lags Revenue Estimates. VAXART, INC. (VXRT) delivered earnings and revenue surprises of 0% and 69.55%, respectively, for the quarter ended December 2021.
Will vaxart go back up?
During the day the stock fluctuated 5.68% from a day low at $4.58 to a day high of $4.84. The price has fallen in 6 of the last 10 days and is down by -10.9% for this period.
…
Predicted Opening Price for Vaxart of Wednesday, April 13, 2022.
| Fair opening price April 13, 2022 | Current price |
|---|---|
| $4.69 | $4.66 (Undervalued) |
Is vaxart a public company?
Vaxart has a collaborative development program for oral delivery of a vaccine against universal flu using proprietary antigens from Janssen Pharmaceutica (Janssen Vaccines and Prevention B.V.).
…
Vaxart.
| Vaxart’s HQ located in South San Francisco | |
|---|---|
| Type | Public |
| Traded as | Nasdaq: VXRT |
| Industry | Biotechnology |
| Founded | 2004 |
Who is Andrei Floroiu?
Director, Chief Executive & Financial Officer, Vaxart, Inc.
Founder of Fly for MS, Andrei Floroiu is Director, Chief Executive & Financial Officer of Vaxart, Inc.
Is vaxart a good stock?
The verdict. While Vaxart’s oral vaccine could be a game-changer if approved, it is nowhere near reaching that milestone. A lot can still go wrong for the company, and since it does not currently have any products on the market and is consistently unprofitable, that makes the company’s shares very risky.
Why is vaxart going up today?
What happened. Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration (FDA) had cleared its Investigational New Drug (IND) application for its oral coronavirus vaccine. As of 2:20 p.m. EDT, Vaxart’s stock price was up more than 12%.
Where is vaxart located?
Overview Suggest Edit
| Type | Public | |
|---|---|---|
| Founded | 2004 | |
| HQ | South San Francisco, CA, US | Map |
| Website | vaxart.com | |
| Employee Ratings | 4 | More |
What phase is vaxart in?
Vaxart began its Phase II COVID-19 oral vaccine trials in the U.S. in October 2021 . Data is expected in the first half of 2022.
How do I contact vaxart?
- Contact Email info@vaxart.com.
- Phone Number 8667032712.
What does VXRT company do?
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery system.
What type of vaccine is vaxart?
Vaxart is primarily focused on developing oral recombinant protein vaccines based on its proprietary oral vaccine platform.
Is there an oral Covid vaccine?
Stabilitech is a UK-based biopharma company that has developed a thermally-stable oral vaccine for COVID-19. They are now looking for funding to test the vaccine in clinical trials.
Do oral vaccines exist?
However, only a handful of oral vaccines are licensed, including the oral polio, cholera, and rotavirus vaccines.
How does the oral Covid vaccine work?
The Vaxart oral COVID-19 vaccine targets the spike protein (S) and nucleoprotein (N). The N protein is more conserved (less prone to mutations) than the S protein, and therefore new viral variants may be less likely to escape protection. The N protein is also a good target for T-cell responses.
Is vaxart FDA approved?
2, 2021 /PRNewswire/ — Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines administered by tablet, announced today that the U.S. Food and Drug Administration has cleared Vaxart’s Investigational New Drug application for an S-only oral tablet SARS-CoV-2 vaccine candidate.
Join TheMoney.co community and don’t forget to share this post !
